[1]
Saber A. Sakr, Nahed S. Bassely, Mona A. Sakr, Mahmoud Moawad, and Hassan M. Ahmed, “Immunohistochemical alterations in hepatocellular carcinoma patients treated with doxorubicin”, World J Pharm Sci, vol. 1, no. 2, pp. 28–38, Jul. 2013.